CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 55 filers reported holding CIDARA THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $771,417 | +20.5% | 838,286 | +4.0% | 0.00% | – |
Q4 2023 | $640,015 | -15.7% | 805,871 | 0.0% | 0.00% | – |
Q3 2023 | $759,493 | -7.6% | 805,871 | +10.7% | 0.00% | – |
Q2 2023 | $822,312 | -1.8% | 727,710 | +10.3% | 0.00% | – |
Q1 2023 | $837,777 | +186903.8% | 659,667 | +11.3% | 0.00% | – |
Q4 2022 | $448 | -99.9% | 592,724 | +1.3% | 0.00% | – |
Q3 2022 | $367,000 | +49.8% | 584,981 | +16.5% | 0.00% | – |
Q2 2022 | $245,000 | -38.1% | 502,049 | +5.5% | 0.00% | – |
Q1 2022 | $396,000 | -18.2% | 476,076 | +24.8% | 0.00% | – |
Q4 2021 | $484,000 | -43.3% | 381,618 | 0.0% | 0.00% | – |
Q3 2021 | $854,000 | +16.2% | 381,618 | +4.8% | 0.00% | – |
Q2 2021 | $735,000 | -53.2% | 364,162 | -38.3% | 0.00% | – |
Q1 2021 | $1,570,000 | +72.3% | 590,368 | +29.5% | 0.00% | – |
Q4 2020 | $911,000 | -28.6% | 455,736 | +1.7% | 0.00% | – |
Q3 2020 | $1,276,000 | -21.2% | 448,082 | +2.1% | 0.00% | – |
Q2 2020 | $1,619,000 | +197.1% | 438,754 | +99.4% | 0.00% | – |
Q1 2020 | $545,000 | -39.7% | 220,009 | -6.6% | 0.00% | – |
Q4 2019 | $904,000 | +291.3% | 235,476 | +103.0% | 0.00% | – |
Q3 2019 | $231,000 | +106.2% | 115,992 | +73.2% | 0.00% | – |
Q2 2019 | $112,000 | -32.1% | 66,975 | +7.5% | 0.00% | – |
Q1 2019 | $165,000 | -43.5% | 62,280 | -50.0% | 0.00% | – |
Q4 2018 | $292,000 | +6.6% | 124,560 | +100.0% | 0.00% | – |
Q3 2018 | $274,000 | -15.2% | 62,280 | 0.0% | 0.00% | – |
Q2 2018 | $323,000 | +85.6% | 62,280 | +42.5% | 0.00% | – |
Q1 2018 | $174,000 | -41.4% | 43,691 | 0.0% | 0.00% | – |
Q4 2017 | $297,000 | -23.5% | 43,691 | -9.0% | 0.00% | – |
Q3 2017 | $388,000 | +8.1% | 47,992 | 0.0% | 0.00% | – |
Q2 2017 | $359,000 | -33.8% | 47,992 | -31.0% | 0.00% | – |
Q1 2017 | $542,000 | -24.8% | 69,547 | +0.2% | 0.00% | – |
Q4 2016 | $721,000 | +65.4% | 69,420 | +82.2% | 0.00% | – |
Q3 2016 | $436,000 | +16.9% | 38,110 | +5.2% | 0.00% | – |
Q2 2016 | $373,000 | +8.7% | 36,240 | +34.1% | 0.00% | – |
Q1 2016 | $343,000 | -24.3% | 27,025 | +2.2% | 0.00% | – |
Q4 2015 | $453,000 | +64.7% | 26,448 | +22.0% | 0.00% | – |
Q3 2015 | $275,000 | – | 21,687 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,163,631 | $3,095,000 | 1.89% |
5AM Venture Management, LLC | 2,006,511 | $5,337,000 | 0.96% |
INTERWEST VENTURE MANAGEMENT CO | 1,356,813 | $3,609,000 | 0.95% |
Omega Fund Management, LLC | 2,005,249 | $5,334,000 | 0.50% |
KNOTT DAVID M | 415,308 | $1,105,000 | 0.47% |
BVF INC/IL | 3,739,704 | $9,948,000 | 0.37% |
West Family Investments, Inc. | 368,910 | $981,000 | 0.36% |
Monashee Investment Management LLC | 369,099 | $982,000 | 0.15% |
GSA CAPITAL PARTNERS LLP | 178,732 | $475,000 | 0.08% |
JEPPSON WEALTH MANAGEMENT, LLC | 47,550 | $126,000 | 0.08% |